Expansion Opportunity CIVCO is investing in new 96,000 square-foot facility and relocating to Iowa City/Coralville with planned occupancy in 2025, signaling capacity to scale production and expand sales reach for ultrasound infection control, high-level disinfection, and needle guidance devices.

Imaging Tech Focus Strong emphasis on ultrasound related accessories, infection control, device guidance, and electromagnetic needle tracking presents cross sell and upsell potential for ultrasound imaging centers, hospitals, and interventional suites seeking integrated solutions.

Collaborative Growth Recent partnerships with Northern Digital Inc and Demcon Life Sciences & Health to develop a CT-compatible, image-guided needle placement demonstrator create joint venture and co-marketing opportunities to showcase CIVCO’s innovations to large medical customers.

Global Market Readiness Sustained 40+ year track record, mid-size revenue range, and notable partnerships position CIVCO as a credible supplier for mid-market hospitals and clinics looking for specialized ultrasound infection control and biopsy guidance tools.

Innovation Pipeline Past product milestones like PEELSafe and ongoing facility expansion imply an active R&D and manufacturing cadence, enabling targeted outreach for procurement managers seeking new probe covers, disinfection protocols, and precision guidance components.